Comparison

VEGFR2/KDR Antagonist - 1 mg

Item no. AS-60628
Manufacturer AnaSpec
Amount 1 mg
Category
Type Peptides
Format Lyophilized
Specific against other
Conjugate/Tag Unconjugated
Purity Peak Area by HPLC ≥95%
Sequence H-Ala-Thr-Trp-Leu-Pro-Pro-Arg-OH
Citations Ref: Renno, R. et al. Invest. Ophthalmol. Vis. Sci. 43, 3977 (2002); Brekken, R. et al. Cancer Res. 60, 5117 (2000); Jia, H. et al. J. Biol. Chem. 279, 36148 (2004); Ye, F. Gynecol. Oncol. 94, 125 (2004); Bin?truy-Tournaire, R. et al. EMBO J. 19, 1525 (2000).
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias ATWLPPR
Shipping Condition Room temperature
Available
Manufacturer - Type
Catalog
Manufacturer - Category
Peptides
Manufacturer - Targets
Vascular Endothelial Growth Factor (VEGF)
Shipping Temperature
RT
Storage Conditions
- 20 °C
Molecular Weight
840
Description
This peptide is a specific VEGFR2/KDR heptapeptide antagonist, it binds VEGFR2 (KDR/flk), completely inhibiting VEGF binding to KDR and preventing VEGF-induced angiogenesis in-vivo. It specifically inhibits human endothelial cell proliferation in-vitro and totally abolishes VEGF-induced angiogenesis in-vivo.
Product Group
LB1A1Z
Research Area
Cancer & Apoptosis; Cardiovascular Research / Lyophilized
Sequence One-Letter Code
ATWLPPR
GTIN
5400535157340
Usage
Research use
UNSPSC
12352202

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close